This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
This is Why 3M (MMM) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does 3M (MMM) have what it takes? Let's find out.
Durable Goods Order in June Lags Expectation
by Zacks Equity Research
Durable Goods Order in June Lags Expectation.
Big Day for Q2 Earnings, Econ Data
by Mark Vickery
It's a big day for news items relating to the stock market: economic reads, the start of a new Fed meeting, and a slew of Q2 earnings.
3M (MMM) Q2 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
3M's (MMM) second-quarter 2021 revenues increase 24.7% year over year on account of impressive performance across its segments.
Crane (CR) Q2 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Crane's (CR) second-quarter 2021 revenues increase 23.6% year over year on account of impressive performance across Process Flow Technologies and Payment & Merchandising Technologies segments.
3M (MMM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 15.11% and 4.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: AutoNation, Boyd Gaming, Ford, Ruth's Hospitality and 3M
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AutoNation, Boyd Gaming, Ford, Ruth's Hospitality and 3M
5 Growth Stocks to Buy as US Stock Markets Hit Record Highs
by Tirthankar Chakraborty
With the stock market expected to gain traction in the near term as Delta variant and inflation fears somewhat ebb, it's prudent to invest in growth stocks like AutoNation (AN), Ford (F) & 3M (MMM).
5 Corporate Bigwigs to Buy Ahead of Earnings Results Tomorrow
by Nalak Das
We have narrowed down our search to five corporate giants that are slated to release earnings results tomorrow. These are: AMD, MMM, V, SBUX and MDLZ.
General Electric (GE) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
General Electric (GE) Q2 results to reflect gains from solid product offerings and focus on lowering debts. Weak U.S. onshore wind market and issues in Aviation are likely to have been drags.
Honeywell's (HON) Q2 Earnings, Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Honeywell's (HON) second-quarter 2021 revenues increase 17.8% year over year on impressive performance across all of its segments.
Solid Demand & Cost Woes to Influence 3M's (MMM) Q2 Earnings
by Zacks Equity Research
3M (MMM) Q2 results are likely to reflect gains from a solid product demand, innovations and buyouts. Supply-chain disruptions, and logistics and raw material cost hike are likely to have hurt.
Roper's (ROP) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Roper's (ROP) second-quarter 2021 revenues increase 21.7% year over year on impressive performance across all of its segments.
Carlisle (CSL) Q2 Earnings and Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Carlisle's (CSL) second-quarter 2021 revenues increase 22% year over year on impressive performance across CCM and CFT segments.
Danaher (DHR) Beats on Q2 Earnings, Ups 2021 Core Sales View
by Zacks Equity Research
Danaher's (DHR) Q2 results reflect strength in segmental businesses, the impact of pandemic-led tailwinds and improved margins. Projection for core sales growth, including Cytiva, increases for 2021.
Zacks.com featured highlights include: Best Buy, KLA Corp, Polaris, CDW Corp and 3M Co
by Zacks Equity Research
Zacks.com featured highlights include: Best Buy, KLA Corp, Polaris, CDW Corp and 3M Co
5 High ROE Stocks as Markets Spurn Fears of Virus Resurgence
by Supriyo Bose
Best Buy (BBY), KLA Corporation (KLAC), Polaris (PII), CDW Corporation (CDW) and 3M Company (MMM) are some of the stocks with high ROE to buy as markets spurn fears of coronavirus resurgence.
Honeywell (HON) to Post Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Honeywell's (HON) Q2 earnings are likely to have gained from strength in its businesses along with commercial and operational excellence. Weakness in commercial aerospace might have been a spoilsport.
3M (MMM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $200.82, marking a +1.65% move from the previous day.
3M (MMM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
3M (MMM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Blue-Chip Stocks Poised to Beat Earnings Results This Month
by Nalak Das
The five Dow companies discussed herein are slated to release earnings results this month. These are DOW, V, AAPL, MCD and MMM.
Can 3M (MMM) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
3M (MMM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Netflix, Medtronic, AstraZeneca, 3M and Booking Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, Medtronic, AstraZeneca, 3M and Booking Holdings
Top Research Reports for Netflix, Medtronic & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), Medtronic (MDT), and AstraZeneca (AZN).
3M (MMM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $202.83, marking a +1.62% move from the previous day.